Cargando…
The Potential of Atractylodin-Loaded PLGA Nanoparticles as Chemotherapeutic for Cholangiocarcinoma
BACKGROUNDS: The anti-cholangiocarcinoma (CCA) activity of atractylodin isolated from Atractylodes lacea (Thunb.) DC. has previously been demonstrated both in vitro and in vivo. However, the compound is insoluble in water and must be dissolved in organic solvent which might be harmful to human body....
Autores principales: | Muhamad, Nadda, Plengsuriyakarn, Tullayakorn, Chittasupho, Chuda, Na-Bangchang, Kesara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445967/ https://www.ncbi.nlm.nih.gov/pubmed/32334453 http://dx.doi.org/10.31557/APJCP.2020.21.4.935 |
Ejemplares similares
-
Potential of Alpha-Mangostin-Loaded PLGA Nanoparticles for Cholangiocarcinoma Treatment
por: Tahir, Asma, et al.
Publicado: (2022) -
Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review
por: Muhamad, Nadda, et al.
Publicado: (2018) -
Atractylodes lancea for cholangiocarcinoma: Modulatory effects on CYP1A2 and CYP3A1 and pharmacokinetics in rats and biodistribution in mice
por: Muhamad, Nadda, et al.
Publicado: (2022) -
Modulatory Effects of Atractylodin and β-Eudesmol on Human Cytochrome P450 Enzymes: Potential Drug-Drug Interactions
por: Thiengsusuk, Artitaya, et al.
Publicado: (2023) -
Research and Development of Atractylodes lancea (Thunb) DC. as a Promising Candidate for Cholangiocarcinoma Chemotherapeutics
por: Na-Bangchang, Kesara, et al.
Publicado: (2017)